Neuro-Oncology Reviews
Volume
24 Number 19
15 October 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 19, 15 October
Feng
Y, Xu Q, Fang M, Hu C.
Anlotinib
combined with temozolomide for the treatment of patients with
diffuse midline glioma: a case report and literature
review.
Transl
Cancer Res. 2022 Oct;11(10):3876-3882→.
doi: 10.21037/tcr-22-1073→.
PMID: 36388022→.
Case report, Review. ˍ
Miller
R, Niazi M, Russial O, Poiset S, Shi W.
Tumor
treating fields with radiation for glioblastoma: a narrative
review.
Chin
Clin Oncol. 2022 Oct;11(5):40→.
doi: 10.21037/cco-22-90→.
PMID: 36336899→.
Review. ˍ
Zhang
J, Wang Y, Wang Y, Xiao H, Chen X, Lei Y, Feng Z, Ma X, Ma
L.
Perfusion
magnetic resonance imaging in the differentiation between glioma
recurrence and pseudoprogression: a systematic review,
meta-analysis and meta-regression.
Quant
Imaging Med Surg. 2022 Oct;12(10):4805-4822→.
doi: 10.21037/qims-22-32→.
PMID: 36185045→.
Review, Meta-analysis. ˍ
Zwicker
J.
Prevention
and treatment of venous thromboembolism in primary and metastatic
brain cancer.
Clin
Adv Hematol Oncol. 2022 Oct;20(10):594-596→.
PMID: 36206070→.
Interview. ˍ
Buccarelli
M, Castellani G, Ricci-Vitiani L.
Glioblastoma-Specific
Strategies of Vascularization: Implications in Anti-Angiogenic
Therapy Resistance.
J
Pers Med. 2022 Oct 1;12(10):1625→.
doi: 10.3390/jpm12101625→.
PMID: 36294763→.
Review. ˍ
Daneshimehr
F, Barabadi Z, Abdolahi S, Soleimani M, Verdi J, Ebrahimi-Barough
S, Ai J.
Angiogenesis
and Its Targeting in Glioblastoma with Focus on Clinical
Approaches.
Cell
J. 2022 Oct 1;24(10):555-568→.
doi: 10.22074/cellj.2022.8154→.
PMID: 36259473→.
Review. ˍ
Chatterjee
A, Asija S, Yadav S, Purwar R, Goda JS.
Clinical
utility of CAR T cell therapy in brain tumors: Lessons learned
from the past, current evidence and the future stakes.
Int
Rev Immunol. 2022 Oct 3:1-19→.
doi: 10.1080/08830185.2022.2125963→.
PMID: 36191126→.
Review˰ ˍ
Guha
A, Goda JS, Dasgupta A, Mahajan A, Halder S, Gawde J, Talole
S.
Classifying
primary central nervous system lymphoma from glioblastoma using
deep learning and radiomics based machine learning approach - a
systematic review and meta-analysis.
Front
Oncol. 2022 Oct 3;12:884173→.
doi: 10.3389/fonc.2022.884173→.
PMID: 36263203→.
Review, Meta-analysis. ˍ
Jamshidi
P, Brat DJ.
The
2021 WHO classification of central nervous system tumors: what
neurologists need to know.
Curr
Opin Neurol. 2022 Oct 4→.
doi: 10.1097/WCO.0000000000001109→.
PMID: 36226717→.
Review˰ ˍ
van
den Elshout R, Scheenen TWJ, Driessen CML, Smeenk RJ, Meijer FJA,
Henssen D.
Diffusion
imaging could aid to differentiate between glioma progression and
treatment-related abnormalities: a meta-analysis.
Insights
Imaging. 2022 Oct 4;13(1):158→.
doi: 10.1186/s13244-022-01295-4→.
PMID: 36194373→.
Meta-analysis. ˍ
Choi
SI, Yin J.
Prospective
approaches to enhancing CAR T cell therapy for glioblastoma.
Front
Immunol. 2022 Oct 6;13:1008751→.
doi: 10.3389/fimmu.2022.1008751→.
PMID: 36275671→.
Review. ˍ
Ekhator
C, Nwankwo I, Rak E, Homayoonfar A, Fonkem E, Rak R.
GammaTile:
Comprehensive Review of a Novel Radioactive Intraoperative
Seed-Loading Device for the Treatment of Brain Tumors.
Cureus.
2022 Oct 6;14(10):e29970→.
doi: 10.7759/cureus.29970→.
PMID: 36225241→.
Review. ˍ
Sánchez-Villalobos
JM, Aledo-Serrano Á, Villegas-Martínez I, Shaikh MF,
Alcaraz M.
Epilepsy
treatment in neuro-oncology: A rationale for drug choice in common
clinical scenarios.
Front
Pharmacol. 2022 Oct 6;13:991244→.
doi: 10.3389/fphar.2022.991244→.
PMID: 36278161→.
Review. ˍ
Hersh
AM, Bhimreddy M, Weber-Levine C, Jiang K, Alomari S, Theodore N,
Manbachi A, Tyler BM.
Applications
of Focused Ultrasound for the Treatment of Glioblastoma: A New
Frontier.
Cancers
(Basel). 2022 Oct 8;14(19):4920→.
doi: 10.3390/cancers14194920→.
PMID: 36230843→.
Review. ˍ
Campbell
BK, Gao Z, Corcoran NM, Stylli SS, Hovens CM.
Molecular
Mechanisms Driving the Formation of Brain Metastases.
Cancers
(Basel). 2022 Oct 10;14(19):4963→.
doi: 10.3390/cancers14194963→.
PMID: 36230886→.
Review. ˍ
Wang K, Zhang F, Wen C, Huang Z, Hu Z, Zhang Y, Hu F, Wen
L.
Regulation of pathological
blood-brain barrier for intracranial enhanced drug delivery and
anti-glioblastoma therapeutics.
Oncol
Res. 2022 Oct 10;29(5):351-363→.
doi: 10.32604/or.2022.025696→.
PMID: 37305160→.
Review. ˍ
Schakelaar
MY, Monnikhof M, Crnko S, Pijnappel E, Meeldijk J, Ten Broeke T,
Bovenschen N.
Cellular
Immunotherapy for Medulloblastoma.
Neuro
Oncol. 2022 Oct 11:noac236→.
doi: 10.1093/neuonc/noac236→.
PMID: 36219688→.
Review. ˍ
Mahmoud
AB, Ajina R, Aref S, Darwish M, Alsayb M, Taher M, AlSharif SA,
Hashem AM, Alkayyal AA.
Advances
in immunotherapy for glioblastoma multiforme.
Front
Immunol. 2022 Oct 12;13:944452→.
doi: 10.3389/fimmu.2022.944452→.
PMID: 36311781→.
Review.
Miller
JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow
J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL,
Bindra R, Cahill DP, Chang SM, Costello JF, Horbinski C, Huang RY,
Jenkins RB, Ligon KL, Mellinghoff IK, Nabors LB, Platten M,
Reardon DA, Shi DD, Schiff D, Wick W, Yan H, von Deimling A, van
den Bent M, Kaelin WG, Wen PY.
Isocitrate
dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology
(SNO) consensus review on diagnosis, management, and future
directions.
Neuro
Oncol. 2022 Oct 12:noac207→.
doi: 10.1093/neuonc/noac207→.
PMID: 36239925→.
Review. ˍ
Bartusik-Aebisher
D, Żołyniak A, Barnaś E, Machorowska-Pieniążek
A, Oleś P, Kawczyk-Krupka A, Aebisher D.
The
Use of Photodynamic Therapy in the Treatment of Brain Tumors-A
Review of the Literature.
Molecules.
2022 Oct 13;27(20):6847→.
doi: 10.3390/molecules27206847→.
PMID: 36296440→.
Review. ˍ
van
Bree NFHN, Wilhelm M.
The
Tumor Microenvironment of Medulloblastoma: An Intricate
Multicellular Network with Therapeutic Potential.
Cancers
(Basel). 2022 Oct 13;14(20):5009→.
doi: 10.3390/cancers14205009→.
PMID: 36291792→.
Review. ˍ
Zhuang
Q, Yang H, Mao Y.
The
Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical
Opportunities.
Neurosci
Bull. 2022 Oct 13→.
doi: 10.1007/s12264-022-00953-3→.
PMID: 36229714→.
Review. ˍ
Zaed
I, Della Pepa GM, Cannizzaro D, Menna G, Cardia A.
Applicability
and efficacy of ultrasound elastography in neurosurgery: a
systematic review of the literature.
J
Neurosurg Sci. 2022 Oct 14→.
doi: 10.23736/S0390-5616.22.05866-0→.
PMID: 36239425→.
Review˰ ˍ
Gaca-Tabaszewska
M, Bogusiewicz J, Bojko B.
Metabolomic
and Lipidomic Profiling of Gliomas-A New Direction in Personalized
Therapies.
Cancers
(Basel). 2022 Oct 14;14(20):5041→.
doi: 10.3390/cancers14205041→.
PMID: 36291824→.
Review. ˍ
Gueble
SE, Vasquez JC, Bindra RS.
The
Role of PARP Inhibitors in Patients with Primary Malignant Central
Nervous System Tumors.
Curr
Treat Options Oncol. 2022 Oct 15;23(11):1566-1589→.
doi: 10.1007/s11864-022-01024-5→.
PMID: 36242713→.
Review˰ ˍ